Navigation Links
NxStage Launches Nurse Hero Campaign to Recognize Home Hemodialysis Nurses
Date:8/25/2014

LAWRENCE, Mass., Aug. 25, 2014 /PRNewswire/ -- NxStage® Medical, Inc., a leading manufacturer of innovative dialysis products, today launched the Nurse Hero Campaign a first-of-its-kind home hemodialysis nurse recognition that honors the dedication and compassion of the nephrology nursing community. Beginning today, patients, nephrologists and fellow nurses can nominate their "Nurse Hero," a home hemodialysis nurse who has exhibited exceptional devotion and passion to their dialysis patients' well-being and happiness. Nominations can be submitted online at www.Nxstage.com/hero to be featured for voting during Nephrology Nurses Week. The nurse with the most votes will be announced mid-October with a video on the NxStage website.

"I've been in the home program for 8 years and they have been my most gratifying years as a nurse," said Melanie Porter, RN, who has been a dialysis nurse for over 20 years. "Thanks to NxStage and the System One™, I feel patients' gratitude every day. This heartwarming and humbling campaign gives us, as home hemodialysis nurses, the rare opportunity to be recognized by the people we so deeply care about, as well as a chance to show people how passionate we are about making a difference in people's quality of life."

Patients, nurses, and physicians may nominate their "Nurse Heroes" by visiting www.Nxstage.com/hero between August 25 and September 8. Voting will occur from September 9 to September 19, and the winner will be announced on October 14. Nominations are open to all home hemodialysis nurses.

Following the training nurses provide on the System One, patients often report an increased sense of freedom and flexibility when they can perform their own care at home. The Nurse Hero campaign allows patients to express sentiments of appreciation for the extraordinary care these "Nurse Heroes" provide to countless, and sometimes fearful, patients on a daily basis.

"Simply put, there is no more pivotal role than the home training nurse in making life-changing home hemodialysis therapy and its tremendous benefits available to patients" said Joe Turk, president of NxStage Medical, Inc. "The Nurse Hero campaign allows patients and healthcare professionals to recognize this, showing their appreciation and respect for each nurse's personal investment in patient well-being."

To learn more about NxStage's Nurse Hero Contest or about NxStage Medical, Inc., visit www.nxstage.com. Join the conversation on Facebook at facebook.com/NxStage, Twitter at @NxStage and YouTube at youtube.com/user/NxStage.

Despite the health benefits that home hemodialysis may provide to those with chronic kidney disease, this form of therapy is not for everyone. The reported benefits of home hemodialysis may not be experienced by all patients. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream and blood loss due to clotting or accidental disconnection of the blood tubing set. Certain risks are unique to the home. Treatments at home are done without the presence of medical personnel and on-site technical support. Patients and their partners must be trained on what to do and how to get medical or technical help if needed.

About the NxStage System One 
The NxStage System One is the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration (FDA). Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy. When combined with the NxStage PureFlow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs - at home or on vacation and at a medically appropriate treatment frequency. http://www.nxstage.com/.

About NxStage Medical NxStage Medical, Inc.  
NxStage is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.

Forward-Looking Statements 
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2014. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: 
Kristen K. Sheppard, Esq.
VP, Investor Relations
ksheppard@nxstage.com

Logo - http://photos.prnewswire.com/prnh/20110503/MM94799LOGO


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Allan J. Collins, M.D., to join NxStage as Senior Medical Advisor
2. NxStage Reports Record Second Quarter 2014 Financial Results And Increases Full-Year Revenue Guidance
3. NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference
4. NxStage Drives to Educate Kidney Patients
5. NxStage Increases Revenue Guidance for Fourth Quarter and Full-Year 2013
6. NxStage to Present at the 32nd Annual J.P. Morgan Healthcare Conference
7. NxStage Reports Third Quarter 2013 Financial Results
8. NxStage Medical Introduces New Products at 2013 American Society of Nephrology Meeting
9. NxStage Announces Fourth Quarter 2013 Investor Conference Schedule
10. NxStage Introduces Web-Based Dosing Calculator
11. NxStage Urges CMS to Fix Training Reimbursement to Provide Medicare Patients Greater Access to Life-Changing Home Hemodialysis Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
Breaking Medicine News(10 mins):